larotrectinib Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer The partners are starting by testing patients with colorectal and thyroid cancers using the 648-gene Tempus xT assay, but could expand to other areas in the future. FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients The test analyzes substitutions, insertion and deletion alterations, and copy number alterations in 324 genes, along with some genomic signatures in solid tumors. ArcherDx Targeting $100M in IPO ArcherDx has leveraged next-generation sequencing to develop and commercialize more than 325 research-use-only products and a pan-solid tumor diagnostic test. Bayer, OrigiMed Form Companion Diagnostic Development Alliance Under the deal, the companies aim to develop a companion diagnostic for Bayer's solid tumor drug larotrectinib for the Chinese market. Foundation Medicine to Seek FDA Approval for FoundationOne as CDx to Genentech's Rozlytrek The FDA has granted accelerated approval to Rozlytrek as a treatment for adult and adolescent patients with NTRK fusion-positive cancers. Jun 6, 2019 TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts Premium May 29, 2019 Bayer, Foundation Medicine Partner on NGS-Based Companion Diagnostic Test Development May 16, 2019 NCI Pediatric MATCH Trial Interim Data Shows 24 Percent of Patients Eligible for Targeted Therapy Premium May 16, 2019 Roche Drug Shows Benefit in Pediatric Patients With Rare, Molecularly Defined Tumors Premium Apr 2, 2019 Bayer, Loxo Next-Generation TRK Inhibitor Shows Promising Activity in AACR Study Premium Jan 8, 2019 Circulogene Broadens Push Into Companion Diagnostics with NTRK Fusion Assay Premium Nov 27, 2018 Loxo's Pan-Cancer Drug Garners FDA Approval for Patients With NTRK Fusions Apr 10, 2018 Illumina, Loxo Oncology to Develop Pan-Cancer Companion Diagnostic Jun 3, 2017 Loxo Oncology to Seek FDA Approval for Pan-Cancer Drug in Patients with TRK Fusions Premium Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.